Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Paradigm to Be Acquired by Patient Square Capital
Paradigm, a specialty care management organization known for supporting individuals with complex injuries and serious medical conditions, has agreed to be acquired by Patient Square Capital, a healthcare focused investment firm. The agreement signals a new chapter for Paradigm as it looks to expand its reach and strengthen its services across workers compensation and broader payer markets. The move also brings to a close the company’s partnership with OMERS Private Equity, which has supported Paradigm’s growth and strategic direction in recent years.
RevolutionEHR Modern Portal Boosts Optometry Care
RevolutionEHR, a cloud based EHR and practice management platform built for optometry practices, has introduced early access to a newly redesigned patient portal. The updated portal is built to simplify how practices connect with patients while reducing administrative strain on staff. By bringing appointment scheduling, billing, secure messaging, and access to health records together in one streamlined interface, the platform creates a smoother experience for both patients and practice teams.
Anterior Raises $40 Million to Expand AI Adoption in Health Plans
Anterior, a clinician-led artificial intelligence platform designed for health plans, has announced a $40 million funding round, bringing its total capital raised to $64 million. The round was oversubscribed and included continued support from NEA and Sequoia Capital as well as new investment from FPV and Kinnevik. Anterior’s platform enables health insurers to deploy AI directly into clinical and operational workflows, pairing advanced technology with embedded clinicians who work alongside health plan staff to optimize accuracy, accelerate adoption, and ensure measurable outcomes.
Tempus, Median Partner on AI Lung Screening
Tempus AI, Inc. has entered into a collaboration with Median Technologies to integrate Median’s lung cancer screening solution, eyonis LCS, into the Tempus Pixel platform. Tempus is widely recognized for advancing precision medicine through artificial intelligence, and this partnership is aimed at strengthening clinical decision making in lung cancer detection and management. By incorporating Median’s technology into Pixel, Tempus is expanding the tools available to radiologists and care teams who rely on imaging data to guide diagnosis and treatment planning.
Thermo Fisher Partners with Datavant to Boost Real-World Data Use
Thermo Fisher Scientific, a global leader in serving science, has announced a strategic partnership with Datavant to improve how real-world data connects with clinical research. The collaboration will help pharmaceutical and biotech companies generate stronger evidence more efficiently and enable faster insights into patient outcomes.
TheraB Medical Acquired by Natus Sensory to Boost Neonatal Care
TheraB Medical, a Michigan-based pioneer in wearable phototherapy for newborn jaundice, has been acquired by Natus Sensory, a global leader in sensory and neonatal care solutions. This acquisition aims to broaden the availability of TheraB’s signature product, SnugLit, while supporting Natus Sensory’s commitment to family-centered care for infants. SnugLit is a wearable phototherapy device designed following American Academy of Pediatrics guidelines to treat neonatal jaundice. It provides full-body coverage in a soft, swaddle-like design that eliminates the need for protective eye gear required in traditional phototherapy. Its portable and user-friendly design allows parents to maintain close interaction with their infants, including bonding and breastfeeding, while ensuring uninterrupted treatment. The device is suitable for use across various clinical settings, promoting continuity of care and a patient-centered treatment approach.
Sutter Health Partners with OpenEvidence for AI-Powered Insights
Sutter Health has partnered with OpenEvidence to bring AI-driven, evidence-based insights directly into physician workflows within electronic health records. This collaboration aims to help clinicians quickly access the latest medical data and guidelines, enhancing clinical decision-making and supporting Sutter’s commitment to quality, safety, and patient-centered care.
athenahealth, B.well Launch Patient-Controlled Health Data Sharing
athenahealth and b.well Connected Health have introduced a new workflow at the point of care that allows patients to securely share their health information digitally during intake without relying on paper forms, faxes, or multiple portal logins. The companies plan to expand this capability more widely in 2026. This initiative supports the Centers for Medicare & Medicaid Services’ Health Tech Ecosystem Initiative, which aims to replace manual intake and fragmented data exchange with patient-directed tools, a program also known as Kill the Clipboard.
Streamline Healthcare Names Danny Gladden Chief Clinical Officer
Streamline Healthcare Solutions has announced that Danny Gladden, MBA, MSW, LCSW, will join the company as Chief Clinical Officer. Gladden brings over 20 years of experience in behavioral health and social care, spanning clinical practice, operations, and healthcare technology. Prior to joining Streamline, he served as General Manager and Director of Behavioral Health and Social Care at Oracle Health, where he supported leading behavioral health organizations across the United States. As a licensed clinical social worker, Gladden has spent his career ensuring that technology effectively supports clinicians, care delivery, and real-world workflows.
TransMedics Gets FDA IDE Approval for OCS Heart ENHANCE Trial
TransMedics Group, Inc., a medical technology company focused on improving outcomes for patients with end-stage heart, lung, and liver failure, announced that the U.S. Food and Drug Administration has granted full and unconditional approval of its Investigational Device Exemption for the Next-Generation OCS ENHANCE Heart trial. This follows the full IDE approval for the company’s DENOVO Lung trial in January 2026 and the conditional IDE approval for ENHANCE Heart granted in August 2025.
Connie Implements PIQXL Gateway to Advance Data Quality Across Connecticut
Connie, Connecticut’s state-designated Health Information Exchange, has implemented Clinical Architecture’s PIQXL Gateway to help healthcare organizations across the state assess and enhance the quality of shared patient data. The project is supported by a grant from the Connecticut Health Foundation and aims to help Connie strengthen adherence to state standards for collecting and using race, ethnicity, and language, or REL, data. This initiative will provide healthcare providers with greater confidence in the accuracy of information used for patient care and coordination.
Chris Gengo Named SVP and Chief Innovation Officer at HiLabs
HiLabs, a leading provider of AI-driven solutions for cleaning and standardizing complex healthcare data, announced that Chris Gengo has joined the company as Senior Vice President and Chief Innovation Officer. In this role, Gengo will drive innovation across the organization, enhancing HiLabs’ platform to tackle the most persistent data and operational challenges faced by health plans.
SOPHiA GENETICS Expands in US with Two Health Systems
SOPHiA GENETICS, has expanded its footprint in the United States by partnering with two of the country’s largest integrated health systems. The newly signed organizations represent a major addition to the company’s growing network and collectively process millions of genetic samples each year. One of the partners is among the largest nonprofit, multi region healthcare providers in the nation, while the other ranks within the top ten health system laboratories in the United States. Both institutions will implement the cloud based SOPHiA DDM platform to support large scale genomic data analysis and strengthen their precision medicine capabilities.
To share your insights, please write to us at sudipto@intentamplify.com
